HBP.TO
Helix Biopharma Corp
Price:  
0.92 
CAD
Volume:  
500.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBP.TO Relative Valuation

-101.5%
Upside

As of 2025-06-20, the Relative Valuation of Helix Biopharma Corp (HBP.TO) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.92 CAD, the upside of Helix Biopharma Corp based on Relative Valuation is -101.5%.

The range of the Relative Valuation is (0.01) - (0.04) CAD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 0.1x - 0.3x 0.1x
Forward P/E multiples 0.1x - 0.3x 0.1x
Fair Price (0.01) - (0.04) (0.01)
Upside -101.2% - -104.4% -101.5%
0.92 CAD
Stock Price
(0.01) CAD
Fair Price

HBP.TO Relative Valuation - Historical P/E Data

Date P/E
2025-05-28 -6.87
2025-05-27 -6.87
2025-05-26 -7.10
2025-05-22 -7.17
2025-05-20 -7.10
2025-05-16 -7.17
2025-05-15 -7.25
2025-05-14 -7.17
2025-05-13 -7.17
2025-05-12 -7.17
2025-05-09 -7.17
2025-05-08 -7.10
2025-05-06 -7.17
2025-05-01 -7.17
2025-04-30 -7.17
2025-04-29 -5.83
2025-04-28 -5.83
2025-04-25 -5.83
2025-04-24 -5.83
2025-04-23 -5.83
2025-04-22 -5.75
2025-04-15 -5.83
2025-04-14 -5.83
2025-04-11 -5.75
2025-04-03 -5.90
2025-04-02 -5.86
2025-04-01 -5.98
2025-03-31 -5.98
2025-03-26 -5.98
2025-03-19 -5.98
2025-03-18 -7.10
2025-03-14 -6.72
2025-03-13 -6.57